ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 (Updated July 29, 2024).

MLA

“ME3BP-7 Is a Targeted Cytotoxic Agent That Rapidly Kills Pancreatic Cancer Cells Expressing High Levels of Monocarboxylate Transporter MCT1 (Updated July 29, 2024).” Clinical Trials Week, Aug. 2024, p. 529. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178924400&authtype=sso&custid=ns315887.

APA

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 (Updated July 29, 2024). (2024). Clinical Trials Week, 529.

Chicago

“ME3BP-7 Is a Targeted Cytotoxic Agent That Rapidly Kills Pancreatic Cancer Cells Expressing High Levels of Monocarboxylate Transporter MCT1 (Updated July 29, 2024).” 2024. Clinical Trials Week, August, 529. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178924400&authtype=sso&custid=ns315887.